Literature DB >> 3153289

Focal segmental glomerulosclerosis in children: comparison of nonedematous and edematous patients.

S Roy1, F B Stapleton.   

Abstract

Persistent proteinuria without edema, associated with focal segmental glomerulosclerosis (FSGS), has been increasingly observed in our pediatric population. The clinical and pathological features and long-term outcome of these patients are poorly understood and less frequently reported. Ten nonedematous children (10.3 +/- 1.4 years) with proteinuria and FSGS are compared with 16 children (9.0 +/- 0.4 years) with FSGS and nephrotic syndrome (NS). Urinary protein excretion and serum cholesterol were statistically higher and serum albumin statistically lower in the children with FSGS-NS. The percentage of glomeruli with sclerosis was similar in the two groups. Mesangial proliferation was observed more frequently in the nephrotic children and focal or diffuse tubular atrophy more often in the nonedematous children with FSGS. Followup serum creatinines are more than 1 SD above the mean for age in 3 of 10 nonedematous patients with FSGS and 9 of 16 patients with FSGS-NS. Of 10 nonedematous patients with FSGS, 1 progressed to renal failure 20 months after diagnosis, while 3 of 16 patients with FSGS-NS progressed to renal failure. We conclude from these data that NS is a poor prognostic sign in FSGS in children and that neither the percentage of glomeruli with sclerosis nor the presence of tubular atrophy is predictive of NS in our patients.

Entities:  

Mesh:

Year:  1987        PMID: 3153289     DOI: 10.1007/bf00849224

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.

Authors:  M Abramowicz; H L Barnett; C M Edelmann; I Greifer; O Kobayashi; G C Arneil; B A Barron; G Gordillo-P; N Hallman; H A Tiddens
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

2.  Nephrotic syndrome and multiple tubular defects in children: an early sign of focal segmental glomerulosclerosis.

Authors:  M McVicar; R Exeni; M Susin
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

3.  The prognosis of focal segmental glomerular sclerosis of adulthood.

Authors:  S M Korbet; M M Schwartz; E J Lewis
Journal:  Medicine (Baltimore)       Date:  1986-09       Impact factor: 1.889

4.  Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS").

Authors:  C B Brown; J S Cameron; D R Turner; C Chantler; C S Ogg; D G Williams; M Bewick
Journal:  Clin Nephrol       Date:  1978-08       Impact factor: 0.975

5.  Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis.

Authors:  J A Velosa; K E Holley; V E Torres; K P Offord
Journal:  Mayo Clin Proc       Date:  1983-09       Impact factor: 7.616

6.  The long-term prognosis of patients with focal segmental glomerulosclerosis.

Authors:  J S Cameron; D R Turner; C S Ogg; C Chantler; D G Williams
Journal:  Clin Nephrol       Date:  1978-12       Impact factor: 0.975

7.  The significance of focal sclerotic lesions of glomeruli in children.

Authors:  M A Nash; I Greifer; H Olbing; J Bernstein; B Bennett; A Spitzer
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

8.  Focal glomerulosclerosis. Extent of involvement related to steroid resistance.

Authors:  E C Kohaut; G A Edwards; L L Hill; H S Rosenberg; M W Hartley
Journal:  Am J Clin Pathol       Date:  1981-02       Impact factor: 2.493

9.  Focal segmental glomerulosclerosis with and without nephrotic syndrome in children.

Authors:  N Yoshikawa; H Ito; R Akamatsu; S Matsuyama; O Hasegawa; C Nakahara; T Matsuo
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

10.  The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children.

Authors:  M J Schoeneman; B Bennett; I Greifer
Journal:  Clin Nephrol       Date:  1978-02       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.